US equities |
SPCX $174.48 ▲+1.98% NVDA $241.71 ▲+1.18% MU $1,063.91 ▼-0.00% MRVL $291.29 ▲+7.39% AMD $646.40 ▲+2.32% SNDK $1,667.42 ▼-2.16% TSLA $380.48 ▲+0.46% AVGO $375.13 ▲+3.48%
FinancialContent

908 Devices Inc. - Common Stock (NQ:MASS)

12.44 -0.36 (-2.81%)
Delayed Quote Updated: 10:27 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 908 Devices Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
From 908 Devices
Via Business Wire
News headline image
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates ↗
908 Devices (NASDAQ:MASS) outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing... 
Via MarketBeat
News headline image
908 Devices (MASS) Q2 2026 Earnings Call Transcript ↗
Revenue grew 23% to $16.1 million as adjusted EBITDA loss improved 50%. 
Via The Motley Fool
Topics Earnings
908 Devices (NASDAQ:MASS) Qualifies for Minervini Trend Template and High-Growth Momentum Screen ↗
Via Chartmill
908 Devices Inc (NASDAQ:MASS) Reports Solid Q1 Revenue and Raised 2026 Guidance ↗
Via Chartmill
908 Devices Inc. (NASDAQ:MASS) Surpasses Q4 Revenue Estimates and Achieves Profitability Milestone ↗
Via Chartmill
News headline image
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market ↗
908 Devices (NASDAQ:MASS) is sharpening its focus on handheld chemical and drug detection systems for public safety, defense and law enforcement following the divestiture of its bioprocessing and... 
Via MarketBeat
Topics Initial Public Offering
News headline image
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Q2 Earnings Call Highlights ↗
908 Devices (NASDAQ:MASS) reported second-quarter revenue growth of 23% as demand from U.S. state and local government customers, FTIR product shipments and its recently acquired NIRLab platform... 
Via MarketBeat
Topics Earnings
News headline image
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices MASS Q1 2026 Earnings Transcript ↗
908 Devices MASS Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From 908 Devices Inc.
Via Business Wire
News headline image
Sidoti Events, LLC's March Small-Cap Virtual Conference
Via ACCESS Newswire
News headline image
908 Devices to Present at the Sidoti Small Cap Conference
From 908 Devices
Via Business Wire
News headline image
908 Devices (MASS) Q4 2025 Earnings Transcript ↗
908 Devices (MASS) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices to Participate in Investor Conferences in March
From 908 Devices
Via Business Wire
News headline image
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Enhances MX908 Usability and Adds New Drug Targets
From 908 Devices Inc.
Via Business Wire
News headline image
908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
From 908 Devices Inc.
Via Business Wire
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
908 Devices (MASS) Q3 2025 Earnings Transcript ↗
908 Devices (MASS) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >